2015 ICD-9-CM Diagnosis Code 271.8
Other specified disorders of carbohydrate transport and metabolism
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 271.8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 271.8 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
271.8 converts approximately to:
- 2015/16 ICD-10-CM E72.52 Trimethylaminuria
Or:
- 2015/16 ICD-10-CM E72.53 Hyperoxaluria
Or:
- 2015/16 ICD-10-CM E74.4 Disorders of pyruvate metabolism and gluconeogenesis
Or:
- 2015/16 ICD-10-CM E74.8 Other specified disorders of carbohydrate metabolism
Or:
- 2015/16 ICD-10-CM E77.1 Defects in glycoprotein degradation
Approximate Synonyms
- Acquired monosaccharide malabsorption
- Adult fucosidosis
- alpha, alpha-Trehalase deficiency
- Antifreeze oxalosis
- Beta-D-mannosidosis
- Carbohydrate deficiency glycoprotein syndrome
- Carbohydrate deficient glycoprotein syndrome
- Carbohydrate-deficient glycoprotein syndrome
- Carbohydrate-deficient glycoprotein syndrome type II
- Carbohydrate-deficient glycoprotein syndrome type III
- Deficiency of alpha-mannosidase
- Deficiency, pyruvate carboxylase
- Deficiency, pyruvate deshydrogenase
- Disorder of carbohydrate absorption
- Disorder of glucose metabolism
- Disorder of glycerate metabolism
- Disorder of glycoprotein metabolism
- Disorders of pyruvate metabolism and gluconeogenesis
- Dysglycemia
- Enteric hyperoxaluria
- Essential benign pentosuria
- Essential pentosuria
- Fucosidosis
- Glycoprotein metabolism disorder
- Hyperglycemic disorder
- Hyperoxaluria
- Impaired glucose tolerance associated with genetic syndrome
- Impaired intestinal epithelial cell transport of carbohydrates
- Infantile fucosidosis
- Insulin resistance - type A
- Insulin resistance - type B
- Juvenile fucosidosis
- Lactate dehydrogenase deficiency
- Mannosidosis
- Mannosidosis, type I
- Mannosidosis, type II
- Nonglucosuric melituria
- Oxalosis
- Primary hyperoxaluria
- Primary hyperoxaluria, type I
- Primary hyperoxaluria, type II
- Pyruvate carboxylase deficiency
- Pyruvate dehydrogenase complex deficiency
- Pyruvate dehydrogenase deficiency
- Pyruvate metabolism and gluconeogenesis disorder
- Secondary oxalosis
- Sialidosis
- Syndrome of carbohydrate intolerance
- Xylosuria
Clinical Information
- Either of two genetic disorders characterized by urinary excretion of large amounts of oxalate, with nephrolithiasis, nephrocalcinosis, early onset of renal failure, and often a generalized deposit of calcium oxalate, resulting from a defect in glyoxalate metabolism
- Lysosomal storage disease caused by defective alpha-l-fucosidase and accumulation of fucose containing glycoconjugates; clinical symptoms include psychomotor deterioration, growth retardation, hepatosplenomegaly, cardiomegaly, and seizures
- Lysosomal storage disease due to defective alpha-mannosidase with resultant oligosaccharide accumulation
- Lysosome storage disease due to alpha-l-fucosidase (e.c. 3.2.1.51) deficiency in leukocytes manifested by abnormal accumulation in tissues and urinary excretion of partially catabolized oligosaccharides, glycoasparagines, and glycolipids with alpha-linked fucose at the nonreducing end of the glycogen chain. The phenotype is variable and may include delayed growth and mental development, progressive neurological deterioration, hurler-like (mucopolysaccharidosis i-h) coarse facies, recurrent infections, visceromegaly, skeletal abnormalities, joint contractures, deafness, and angiokeratoma corporis diffusum. Several types are recognized by different researchers. The form exhibiting a longer survival, mild neurological manifestations, and angiokeratoma is sometimes referred to as fucosidosis type ii. In a different scheme, three different types are recognized according to their age of onset. Types i and ii are the most severe and have their onsets at 10 and 18 months, respectively with life expectancy of 6 years. Type iii represents a juvenile form which is marked by a milder form of psychomotor retardation and a slower deterioration of neurological activities. Hurler-like (gargyloid) facies occur mainly in types i and ii and is less commonly in type iii
Applies To
- Essential benign pentosuria
- Fucosidosis
- Glycolic aciduria
- Hyperoxaluria (primary)
- Mannosidosis
- Oxalosis
- Xylosuria
- Xylulosuria
alpha-fucosidase 271.8
fucosidase 271.8
